You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract

  • Technology appraisal guidance
  • Reference number: TA272
  • Published:  23 January 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: second appeal (rejected)

An appeal has been lodged for this appraisal, however it was rejected. Below are the papers related to this appeal.

For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.

  • Urothelial tract carcinoma (transitional cell, advanced, metastatic) - vinflunine: appeal from Pierre Fabre Ltd


This page was last updated: 23 January 2013

Back to top